SuspendedNCT03513549
Official study titleA Postmarketing Observational Study to Evaluate the Safety of ADASUVE® (STACCATO® Loxapine for Inhalation) in Patients With Agitation Associated With Schizophrenia or Bipolar I Disorder
Recruitment is currently suspended.
In RaleighBipolarity, SchizophreniaObservational studyAges 18+
- Countries
- United States
- Sponsor
- Alexza Pharmaceuticals, Inc.
CompletedNCT03953417
Official study titlePilot Accelerated Theta Burst Stimulation in Treatment-Resistant Bipolar Depression
This study has finished and is no longer accepting participants.
In Palo AltoDepression, BipolarityDevice studyAges 18–80
- Countries
- United States
- Sponsor
- Stanford University
CompletedNCT01527448
Official study titleAn Open Label Dose Titration Study of Quetiapine XR in the Treatment of Postpartum Depression in Nonlactating Women Diagnosed With Bipolar Disorder (BD), Type II.
This study has finished and is no longer accepting participants.
In VancouverBipolarity, DepressionMedication studyAges 19–40
- Countries
- Canada
- Sponsor
- BC Women's Hospital & Health Centre
CompletedNCT00436020
Official study titleA Double-blind Sham Controlled Trial of rTMS in the Treatment of Bipolar Depression
This study has finished and is no longer accepting participants.
In PrahranBipolarity, DepressionDevice studyAges 18–70
- Countries
- Australia
- Sponsor
- Bayside Health
CompletedNCT01093937
Official study titleA 10-Week Pilot Study of Varenicline (Champix) Versus Placebo for Smoking Cessation/Reduction in Patients With Bipolar Disorder
This study has finished and is no longer accepting participants.
In TorontoBipolarity, AddictionMedication studyAges 18–65
- Countries
- Canada
- Sponsor
- Centre for Addiction and Mental Health (Hospital / academic medical center)
CompletedNCT01305408
Official study titleA Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamBipolarity, DepressionMedication studyAges 18–65
- Countries
- United States, Argentina, Brazil, + 11 others
- Sponsor
- Cephalon
CompletedNCT01072630
Official study titleA Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 and 200 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamBipolarity, DepressionMedication studyAges 18–65
- Countries
- United States, Australia, France, + 7 others
- Sponsor
- Cephalon
CompletedNCT03287037
Official study titleTo Investigate the Effect of Transcranial Direct Current Stimulation (tDCS) on Depressive Symptoms, Neurocognitive Function and Heart Rate Variability in Unipolar Depression and Bipolar Depression
This study has finished and is no longer accepting participants.
In TaipeiDepression, BipolarityDevice studyAges 20–65
- Countries
- Taiwan
- Sponsor
- Tri-Service General Hospital (TSGH)
CompletedNCT00186758
Official study titleA Randomized, Sham Controlled, Crossover Trial of rTMS for Bipolar Depression
This study has finished and is no longer accepting participants.
In HamiltonBipolarity, DepressionDevice studyAges 18–65
- Countries
- Canada
- Sponsor
- St. Joseph's Healthcare Hamilton
TerminatedACTRN12616001328460
Official study titleA randomised controlled trial evaluating the addition of Cognitive Remediation to Interpersonal and Social Rhythms Therapy on cognitive functioning, everyday functioning, and mood morbidity in patients with severe mood disorders
This study ended early.
In New ZealandDepression, BipolarityInterventional studyAges 18+
- Countries
- New Zealand
- Sponsor
- University of Otago